To elucidate the expression level of ELAVL2 in clinical and molecular features associated with glioma progression, the mRNA level of ELAVL2 was assessed on various histological and molecular criteria by utilizing several publicly available glioma mRNA datasets retrieved from TCGA, CGGA, IVY GBM, and GSE16011. This evidence concerns the gene ELAVL2 and glioblastoma.